Amend notification No. 16/2017-Customs, dated the 20th April, 2017 so to exempt certain drugs for supply under Patient Assistance Programme run by specified pharmaceutical companies


Quick Summary
This notification amends a previous customs directive from 2017. It introduces an exemption from customs duty for specific drugs. This exemption applies when these drugs are supplied under a Patient Assistance Programme managed by certain pharmaceutical companies. The amendment aims to facilitate access to essential medicines for patients.

GOVERNMENT OF INDIA
MINISTRY OF FINANCE
(Department of Revenue)

Notification No. 09/2025-Customs

New Delhi, the 1st February, 2025

G.S.R….(E).- In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act,
1962 (52 of 1962), the Central Government, on being satisfied that it is necessary in the public interest so to do,hereby makes the following further amendments in the notification of the Government of India in the Ministry of Finance (Department of Revenue) No. 16/2017-Customs, dated the 20th April, 2017, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), vide number G.S.R. 394(E), dated the 20th April, 2017,
namely

Official copy of the circular has been attached

FAQ :

This notification amends a previous customs directive to exempt certain drugs supplied under Patient Assistance Programmes from customs duty.

The notification exempts certain drugs that are supplied under a Patient Assistance Programme run by specified pharmaceutical companies.

A Patient Assistance Programme is a scheme run by pharmaceutical companies to help patients access their medicines.

The original notification being amended is No. 16/2017-Customs, dated the 20th April, 2017.

This amendment is issued by the Central Government, under the powers conferred by the Customs Act, 1962.

 

Guest
Notification No : Notification No. 09/2025-Customs
Published in Custom
Source : https://www.indiabudget.gov.in/doc/cen/cus0925.pdf
Attached File : 322600_11433_cus0925.pdf

Comments



CCI Pro